Related Experiment Videos
Biologic therapy for psoriasis: a brief history, II
W D Tutrone1, M H Kagen, J Barbagallo
1Department of Dermatology, St. Luke's-Roosevelt and Beth Israel Medical Centers, New York, New York 10025, USA.
Cutis
|January 5, 2002
Abstract:
This article, the second in a 2-part series, will review interleukin 10 (IL-10) administration, the T-cell receptor mimic peptide, and CTLA4Ig. We also will review 4 of the most promising therapies currently being investigated for the treatment of psoriasis: infliximab, etanercept, efalizumab, and alefacept.